Correlation Between Cardio Diagnostics and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Edgewise Therapeutics, you can compare the effects of market volatilities on Cardio Diagnostics and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Edgewise Therapeutics.
Diversification Opportunities for Cardio Diagnostics and Edgewise Therapeutics
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cardio and Edgewise is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Edgewise Therapeutics
Assuming the 90 days horizon Cardio Diagnostics Holdings is expected to under-perform the Edgewise Therapeutics. In addition to that, Cardio Diagnostics is 2.27 times more volatile than Edgewise Therapeutics. It trades about -0.31 of its total potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.2 per unit of volatility. If you would invest 3,080 in Edgewise Therapeutics on October 20, 2024 and sell it today you would lose (454.00) from holding Edgewise Therapeutics or give up 14.74% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 95.0% |
| Values | Daily Returns |
Cardio Diagnostics Holdings vs. Edgewise Therapeutics
Performance |
| Timeline |
| Cardio Diagnostics |
| Edgewise Therapeutics |
Cardio Diagnostics and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardio Diagnostics and Edgewise Therapeutics
The main advantage of trading using opposite Cardio Diagnostics and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Cardio Diagnostics vs. Agilent Technologies | Cardio Diagnostics vs. Equillium | Cardio Diagnostics vs. 23Andme Holding Co | Cardio Diagnostics vs. DiaMedica Therapeutics |
| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Transaction History View history of all your transactions and understand their impact on performance |